Exploring the Relationship Between Atorvastatin and Memory Loss: A Comprehensive Analysis Integrating Real-World Pharmacovigilance and Mendelian Randomization-Reference-Cited by-同舟云学术

Exploring the Relationship Between Atorvastatin and Memory Loss: A Comprehensive Analysis Integrating Real-World Pharmacovigilance and Mendelian Randomization

Published:2024-06 Issue:2 Volume:24 Page:317-329
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Chen Kaiqin,Chen Yongtai,Huang Hesen

Funder

Xiamen Municipal Bureau of Science and Technology

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40268-024-00474-6.pdf

Reference61 articles.

1. Wang TJ, Stafford RS, Ausiello JC, Chaisson CE. Randomized clinical trials and recent patterns in the use of statins. Am Heart J. 2001;141(6):957–63. https://doi.org/10.1067/mhj.2001.115587.

2. Do C, Huyghe E, Lapeyre-Mestre M, Montastruc JL, Bagheri H. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database. Drug Saf. 2009;32(7):591–7. https://doi.org/10.2165/00002018-200932070-00005.

3. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult: 2009 recommendations. Can J Cardiol. 2009;25(10):567–79. https://doi.org/10.1016/s0828-282x(09)70715-9.

4. Rojas-Fernandez CH, Cameron JC. Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations. Ann Pharmacother. 2012;46(4):549–57. https://doi.org/10.1345/aph.1Q620.

5. Jamolowicz AI, Chen HY, Panegyres PK. Statins and memory loss: an Australian experience. Australas Med J. 2015;8(3):73–9. https://doi.org/10.4066/AMJ.2015.2014.